Prevalence and Trends in Obesity Among US Adults, 1999-2000

Flegal, Katherine M.; Carroll, Margaret D.; Ogden, Cynthia L.; Johnson, Clifford L.

doi:10.1001/jama.288.14.1723

Cited by 5,983 publications

(3,393 citation statements)

References 22 publications

Supporting

101

Mentioning

3,198

Contrasting

Unclassified

Order By: Relevance

“…The prevalence of obesity increased from 22.9 to 30.5% in the U.S. between NHANES III and NHANES 1999 -2000 (16). Our analyses show that the increase in BMI accounted for much of the increase in the prevalence of the metabolic syndrome.…”

Section: Ford Giles and Mokdadmentioning

confidence: 60%

See 1 more Smart Citation

Increasing Prevalence of the Metabolic Syndrome Among U.S. Adults

2004

View full text Add to dashboard Cite

OBJECTIVE -The prevalence of the metabolic syndrome is high among U.S. adults. Our purpose was to determine whether the prevalence of this syndrome has changed since 1988 -1994. RESEARCH DESIGN AND METHODS-A total of 6,436 men and women aged Ն20 years from the National Health and Nutrition Examination Survey (NHANES) III (1988III ( -1994 and 1,677 participants from NHANES 1999 -2000 were included in the analyses. We used the definition of the metabolic syndrome developed by the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.RESULTS -The unadjusted prevalence of the metabolic syndrome was 23.1% in NHANES III and 26.7% in NHANES 1999 -2000 (P ϭ 0.043), and the age-adjusted prevalences were 24.1 and 27.0% (P ϭ 0.088), respectively. The age-adjusted prevalence increased by 23.5% among women (P ϭ 0.021) and 2.2% among men (P ϭ 0.831). Increases in high blood pressure, waist circumference, and hypertriglyceridemia accounted for much of the increase in the prevalence of the metabolic syndrome, particularly among women.CONCLUSIONS -The increased prevalence of the metabolic syndrome is likely to lead to future increases in diabetes and cardiovascular disease.

show abstract

Section: Ford Giles and Mokdadmentioning

confidence: 60%

“…Because the prevalence of obesity has continued to increase in the U.S. during the 1990s (16,17), we theorized that the prevalence of the metabolic syndrome among adults had increased as well. To test this hypothesis, we used data from two national surveys: the National Health and Nutrition Examination Survey (NHANES) III andNHANES 1999 -2000.…”

mentioning

confidence: 99%

Increasing Prevalence of the Metabolic Syndrome Among U.S. Adults

2004

View full text Add to dashboard Cite

show abstract

“…However, research indicates that the situation is worsening rather than improving (Flegal et al, 2002). Not surprisingly, eating too much and exercising too little exert a great influence on the development of overweight and obesity.…”

Section: Introductionmentioning

confidence: 99%

Healthy Eating Index and obesity

Guo¹,

Warden²,

et al. 2004

View full text Add to dashboard Cite

Background: There is a continuing need to examine the relationship between diet quality and health in the population. The Healthy Eating Index (HEI) has been developed as a composite measure of diet quality by the US Department of Agriculture. Objectives: The first objective was to use the HEI to assess the diet quality of a representative sample of the US population and population groups. The second objective was to examine the association between HEI and obesity. Design: Cross-sectional analysis of data from 10 930 adults who participated in the Third National Health and Nutrition Examination Survey. Sociodemographic, physical activity, dietary, and health data were used in the analysis. Diet quality was assessed with the HEI score, ranging from 0 to 100, based on 10 dietary criteria. A low HEI score indicates poor diet. Results: A majority of survey participants had a low HEI score. The percentage of individuals classified as having a poor diet varied by age, gender, race/ethnicity, income, and education. A low HEI score was associated with overweight and obesity. There was a graded increase in the odds ratio of obesity across the HEI category after adjusting for age, gender, race/ethnicity, physical activity, smoking, alcohol use, income, and education. Conclusions: An index of diet quality, such as HEI, may provide a comprehensive assessment of diet in the population. Since the HEI is based on the US Dietary Guidelines, the use of these guidelines as a way to improve health should be emphasized. However, the overall effectiveness of these guidelines in disease prevention needs to be studied further. Sponsorship: None.

show abstract

“…It affects more than 30% of the general population in USA and more than 10% in Italy. 1,2 Genetic, social, psychological and behavioural factors work in favour of obesity 3 and make it difficult both to prevent and to treat this condition. It is a paradox that, despite the extensive research in the pharmacological treatment of obesity, 4 the number of drugs available for treatment in the past 10 years has decreased as the prevalence of obesity has increased.…”

Section: Introductionmentioning

confidence: 99%

Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study

et al. 2006

View full text Add to dashboard Cite

Objective: The stomach is the main target organ for bariatric surgery, but no medical treatment has been developed to increase satiety and decrease food intake via gastric pathways. The aim of our study was to investigate whether or not the intraparietogastric administration of botulinum toxin A (BTX), able to modify the motility patterns of the stomach, could be useful for treatment of obesity. Design: Double blind controlled study. Subjects: Twenty-four morbidly obese patients (mean weight (s.e.m.) 116.174.89 kg, mean body mass index (BMI) 43.671.09 kg/m 2 ) were blindly randomized to receive 200 IU BTX or placebo into the antrum and fundus of the stomach by intraparietal endoscopic administration. Measurements: We evaluated weight loss, BMI changes, satiety score, the maximal gastric capacity for liquids and the gastric emptying time (octanoic acid breath test). Results: The two groups were homogeneous for anthropometric characteristics. Eight weeks after treatment, BTX patients had significantly higher weight loss (1171.09 vs 5.771.1 kg, Po0.001) and BMI reduction (470.36 vs 270.58 kg/m 2 , Po0.001) and a higher satiety score on a visual analogic scale (7.6370.38 vs 4.7270.44, Po0.001) than controls. Furthermore, BTX patients showed a significantly greater reduction in maximal gastric capacity for liquids (266.6748 vs 139731, Po0.001) and a greater prolongation in gastric emptying time ( þ 18.9378 vs À2.276.9 min, Po0.05). No significant side effects or neurophysiologic changes were found. Conclusions: Topical intragastric BTX was effective in reducing food intake and body weight in morbidly obese patients.

show abstract

Prevalence and Trends in Obesity Among US Adults, 1999-2000

Abstract: The increases in the prevalences of obesity and overweight previously observed continued in 1999-2000. The potential health benefits from reduction in overweight and obesity are of considerable public health importance.

Cited by 5,983 publications

References 22 publications

Increasing Prevalence of the Metabolic Syndrome Among U.S. Adults

Increasing Prevalence of the Metabolic Syndrome Among U.S. Adults

Healthy Eating Index and obesity

Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study

Contact Info

Product

Resources

About